alpha,beta-Thujone suppresses human placental choriocarcinoma cells via metabolic disruption
- Authors
- Lee, Jin-Young; Park, Hahyun; Lim, Whasun; Song, Gwonhwa
- Issue Date
- 6월-2020
- Publisher
- BIOSCIENTIFICA LTD
- Citation
- REPRODUCTION, v.159, no.6, pp.745 - 756
- Indexed
- SCIE
SCOPUS
- Journal Title
- REPRODUCTION
- Volume
- 159
- Number
- 6
- Start Page
- 745
- End Page
- 756
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/55455
- DOI
- 10.1530/REP-20-0018
- ISSN
- 1470-1626
- Abstract
- alpha,beta-Thujone is a natural terpenoid found in many medicinal herbs, such as Artemisia absinthium (wormwood), that exhibits antioxidant, anti-diabetic, and anti-tumorigenic effects. alpha,beta-Thujone has numerous functions; it serves as a food ingredient, cosmetic additive, and medicinal remedy. Although the therapeutic properties of alpha,beta-thujone were previously revealed, a comprehensive description of the mechanisms of its anti-cancer potential in choriocarcinoma is yet to be provided. To our knowledge, this study is the first to demonstrate that alpha,beta-thujone attenuates JEG3 and JAR choriocarcinoma cells through a caspase-dependent intrinsic apoptotic pathway. Moreover, alpha,beta-thujone was demonstrated to induce a global mitochondrial defect and ER stress in choriocarcinoma by causing mitochondrial depolarization, calcium overload, and metabolic alterations, thereby leading to energy deprivation, which eventually contributes to the increase in apoptosis of choriocarcinoma cells. Herein, we also revealed the synergistic anti-cancer activity of alpha,beta-thujone via its sensitization effect on paclitaxel in choriocarcinoma cells. Altogether, our findings suggest that alpha,beta-thujone is a novel, natural pharmacological compound that can be used to treat human placental choriocarcinoma.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biotechnology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.